Skip to main content

Got out of ICPT and waiting for a pullback as it has had a huge run up.  Problem is that it will have a market cap 3-4 x its current one once their drug results come out due to first-to-market status.  They might not get that far before being bought out and I really don’t want to be out when that happens.  The drug *supposedly* has a fairly “easy” phase III hurdle to get over based on changes made to the study expectations by the FDA.  You never know.  It is a buy on a pullback to $85 for me.  Current support is around $92.50 on this recent plateau, but if it starts moving again, the sky is the limit from here (not much resistance).

Also hoping for a small position in VLE.TO (PNWRF for OTC Americans like me) to blast off this winter as another poster on here has hoped.  Success there is probably a 10-20 bagger which is why it is probably a small position I’ll never see again LOL.

robsutherland posted:

Apparently the stocks I like are the best stocks! I just won the Starmine/Thomson Reuters award for Best Stock Picker in my sector!

Yes I am ABSOLUTELY tooting my own horn. 

Congrats! One of my clients was the founder of Starmine and sold out to Thomsen. Needless to say he's comfortably retired and enjoying the wines in the cellar he built

I just bought some Invesque (TSX:IVQ.u) which is paying a 10.6% dividend with a low 70%'s payout ratio and is trading about 35-40% below NAV. Great platform and assets, the last iteration of the company (same management, different assets) was taken out at a massive premium by a US player and after the non-compete ended they've just done the same thing again. It can only trade this far below intrinsic for so long before something happens. 

Add Reply

Post
×
×
×
×
Link copied to your clipboard.
×